175 related articles for article (PubMed ID: 36565124)
1. Age-Related Association Between APOE ɛ4 and Cognitive Progression in de novo Parkinson's Disease.
Liu JY; Ma LZ; Wang J; Cui XJ; Sheng ZH; Fu Y; Li M; Ou YN; Yu JT; Tan L; Lian Y
J Alzheimers Dis; 2023; 91(3):1121-1132. PubMed ID: 36565124
[TBL] [Abstract][Full Text] [Related]
2. An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele.
Shahid M; Kim J; Leaver K; Hendershott T; Zhu D; Cholerton B; Henderson VW; Tian L; Poston KL
Neurobiol Dis; 2019 Jul; 127():278-286. PubMed ID: 30826425
[TBL] [Abstract][Full Text] [Related]
3. Potential Sex-Specific Effects of Apolipoprotein E ɛ4 on Cognitive Decline in Early Parkinson's Disease.
Kim R; Park S; Yoo D; Ju Suh Y; Jun JS; Jeon B
J Parkinsons Dis; 2021; 11(2):497-505. PubMed ID: 33325396
[TBL] [Abstract][Full Text] [Related]
4. Differential Effect of APOE ɛ4 Status and Elevated Pulse Pressure on Functional Decline in Cognitively Normal Older Adults.
Werhane ML; Thomas KR; Edmonds EC; Bangen KJ; Tran M; Clark AL; Nation DA; Gilbert PE; Bondi MW; Delano-Wood L;
J Alzheimers Dis; 2018; 62(4):1567-1578. PubMed ID: 29562507
[TBL] [Abstract][Full Text] [Related]
5. APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.
Paul KC; Rausch R; Creek MM; Sinsheimer JS; Bronstein JM; Bordelon Y; Ritz B
J Parkinsons Dis; 2016 Apr; 6(2):349-59. PubMed ID: 27061069
[TBL] [Abstract][Full Text] [Related]
6. Five-Year Change in Body Mass Index Predicts Conversion to Mild Cognitive Impairment or Dementia Only in APOE ɛ4 Allele Carriers.
Kadey KR; Woodard JL; Moll AC; Nielson KA; Smith JC; Durgerian S; Rao SM
J Alzheimers Dis; 2021; 81(1):189-199. PubMed ID: 33749649
[TBL] [Abstract][Full Text] [Related]
7. Association analyses of apolipoprotein E genotypes and cognitive performance in patients with Parkinson's disease.
Zhu SG; Chen ZL; Xiao K; Wang ZW; Lu WB; Liu RP; Huang SS; Zhu JH; Zhang X; Wang JY
Eur J Med Res; 2024 Jun; 29(1):334. PubMed ID: 38880878
[TBL] [Abstract][Full Text] [Related]
8. APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.
Tropea TF; Xie SX; Rick J; Chahine LM; Dahodwala N; Doshi J; Davatzikos C; Shaw LM; Van Deerlin V; Trojanowski JQ; Weintraub D; Chen-Plotkin AS
Mov Disord; 2018 Feb; 33(2):289-297. PubMed ID: 29168904
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with
Sheng ZH; Ma LZ; Liu JY; Ou YN; Zhao B; Ma YH; Tan L
Front Aging Neurosci; 2022; 14():1061096. PubMed ID: 36589544
[TBL] [Abstract][Full Text] [Related]
10. Association of Physical Activity and
Kim R; Park S; Yoo D; Jun JS; Jeon B
Neurology; 2021 May; 96(19):e2429-e2437. PubMed ID: 33790041
[TBL] [Abstract][Full Text] [Related]
11. Visit-to-Visit Blood Pressure Variability and Cognitive Decline in Apolipoprotein ɛ4 Carriers versus Apolipoprotein ɛ3 Homozygotes.
Sible IJ; Nation DA;
J Alzheimers Dis; 2023; 93(2):533-543. PubMed ID: 37066910
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E ɛ4 (APOE ɛ4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.
Basta M; Zaganas I; Simos P; Koutentaki E; Dimovasili C; Mathioudakis L; Bourbouli M; Panagiotakis S; Kapetanaki S; Vgontzas A
J Alzheimers Dis; 2021; 79(2):763-771. PubMed ID: 33361595
[TBL] [Abstract][Full Text] [Related]
13. Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
Chen XR; Shao Y; Sadowski MJ;
J Alzheimers Dis; 2021; 82(3):921-937. PubMed ID: 34120907
[TBL] [Abstract][Full Text] [Related]
14. Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.
Whitehair DC; Sherzai A; Emond J; Raman R; Aisen PS; Petersen RC; Fleisher AS;
Alzheimers Dement; 2010 Sep; 6(5):412-9. PubMed ID: 20813342
[TBL] [Abstract][Full Text] [Related]
15. Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E ɛ4 with Neuropsychiatric Symptoms in Alzheimer's Disease.
Jiang J; Hong Y; Li W; Wang A; Jiang S; Jiang T; Wang Y; Wang L; Yang S; Ren Q; Zou X; Xu J
J Alzheimers Dis; 2023; 96(2):669-681. PubMed ID: 37840496
[TBL] [Abstract][Full Text] [Related]
16. Subjective Cognitive Decline and APOE ɛ4: A Systematic Review.
Ali JI; Smart CM; Gawryluk JR
J Alzheimers Dis; 2018; 65(1):303-320. PubMed ID: 30040718
[TBL] [Abstract][Full Text] [Related]
17. GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10-Year Population-Based Study.
Szwedo AA; Dalen I; Pedersen KF; Camacho M; Bäckström D; Forsgren L; Tzoulis C; Winder-Rhodes S; Hudson G; Liu G; Scherzer CR; Lawson RA; Yarnall AJ; Williams-Gray CH; Macleod AD; Counsell CE; Tysnes OB; Alves G; Maple-Grødem J;
Mov Disord; 2022 May; 37(5):1016-1027. PubMed ID: 35106798
[TBL] [Abstract][Full Text] [Related]
18. Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.
Bejanin A; Iulita MF; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernandez S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Padilla C; Aranha MR; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Zetterberg H; Blennow K; Alcolea D; Clarimon J; Zaman SH; Blesa R; Lleó A; Fortea J
JAMA Neurol; 2021 Aug; 78(8):937-947. PubMed ID: 34228042
[TBL] [Abstract][Full Text] [Related]
19. Functional segregation loss over time is moderated by APOE genotype in healthy elderly.
Ng KK; Qiu Y; Lo JC; Koay ES; Koh WP; Chee MW; Zhou J
Hum Brain Mapp; 2018 Jul; 39(7):2742-2752. PubMed ID: 29520911
[TBL] [Abstract][Full Text] [Related]
20. An Active Lifestyle Is Associated with Better Cognitive Function Over Time in APOE ɛ4 Non-Carriers.
Fernández-Matarrubia M; Goni L; Rognoni T; Razquin C; Fernández-Lázaro CI; Bes-Rastrollo M; Martínez-González MÁ; Toledo E
J Alzheimers Dis; 2021; 79(3):1257-1268. PubMed ID: 33427740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
